Universal donor stem cells and related methods
AssigneePresident and Fellows of Harvard College
InventorsTorsten B. Meissner, Leonardo M.R. Ferreira, Jack L. Strominger, Chad A. Cowan
Life of this patent
Estimating the term…
Abstract
Disclosed herein are universal donor stem cells and related methods of their use and production. The universal donor stem cells disclosed herein are useful for overcoming the immune rejection in cell-based transplantation therapies. In certain embodiments, the universal donor stem cells disclosed herein have modulated expression of one or more MHC-I and MHC-II human leukocyte antigens and one or more tolerogenic factors.
Claims26
-56. (canceled)
A hypoimmunogenic stem cell comprising three exogenous genes encoding PD-L1, HLA-G, and CD47, respectively, wherein the three exogenous genes are inserted into a safe harbor locus of at least one allele of the hypoimmunogenic stem cell.
A nucleic acid molecule comprising:
- i) an expression cassette comprising:
- a) a first nucleic acid sequence encoding PD-L1,
- b) a second nucleic acid sequence encoding HLA-G, and
- c) a third nucleic acid sequence encoding CD47,
- ii) a promoter that induces overexpression of PD-L1, HLA-G, and CD47, and
- iii) a first arm sequence and a second arm sequence, wherein the first arm sequence is located upstream of the expression cassette and the promoter and the second arm sequence is located downstream of the expression cassette and the promoter, and wherein the arm sequences are homologous to a safe harbor locus of a target stem cell.
A hypoimmunogenic stem cell comprising two exogenous genes encoding PD-L1 and CD47, respectively, wherein the two exogenous genes are inserted into a safe harbor locus of at least one allele of the hypoimmunogenic stem cell.
A nucleic acid molecule comprising:
- i) an expression cassette comprising:
- a) a first nucleic acid sequence encoding PD-L1, and
- b) a second nucleic acid sequence encoding CD47,
- ii) a promoter that induces overexpression of PD-L1 and CD47, and
- iii) a first arm sequence and a second arm sequence, wherein the first arm sequence is located upstream of the expression cassette and the promoter and the second arm sequence is located downstream of the expression cassette and the promoter, and wherein the arm sequences homologous to a safe harbor locus of a target stem cell.
Dependencies are inferred from the claim text.